278 related articles for article (PubMed ID: 25073826)
21. [Screening for colorectal cancer in Italy, 2010 survey].
Zorzi M; Fedato C; Grazzini G; Sassoli de' Bianchi P; Naldoni C; Pendenza M; Sassatelli R; Senore C; Visioli CB; Zappa M
Epidemiol Prev; 2012; 36(6 Suppl 1):55-77. PubMed ID: 23293271
[TBL] [Abstract][Full Text] [Related]
22. Colonoscopy: a review of its yield for cancers and adenomas by indication.
Rex DK
Am J Gastroenterol; 1995 Mar; 90(3):353-65. PubMed ID: 7872270
[TBL] [Abstract][Full Text] [Related]
23. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain).
Peris M; Espinàs JA; Muñoz L; Navarro M; Binefa G; Borràs JM;
J Med Screen; 2007; 14(2):81-6. PubMed ID: 17626707
[TBL] [Abstract][Full Text] [Related]
24. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
25. Colonoscopy requirements of population screening for colorectal cancer in New Zealand.
Green T; Richardson A; Parry S
N Z Med J; 2012 Jun; 125(1356):85-95. PubMed ID: 22729063
[TBL] [Abstract][Full Text] [Related]
26. [Colonoscopic screening of asymptomatic individuals with a family history of colorectal cancer].
Maxim M; Trifan A; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):993-7. PubMed ID: 21500448
[TBL] [Abstract][Full Text] [Related]
27. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening.
van Rossum LG; van Rijn AF; van Oijen MG; Fockens P; Laheij RJ; Verbeek AL; Jansen JB; Dekker E
Int J Cancer; 2009 Aug; 125(4):746-50. PubMed ID: 19408302
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway.
Greuter MJ; Demirel E; Lew JB; Berkhof J; Xu XM; Canfell K; Dekker E; Meijer GA; Coupé VM
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):135-44. PubMed ID: 26598535
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the appropriateness of a community pharmacy model for a colorectal cancer screening program in Catalonia (Spain).
Santolaya M; Aldea M; Grau J; Estrada M; Barau M; Buron A; Francesc M; Castell A; Rodriguez C; Gascón P; Rius P; Guayta-Escolies R;
J Oncol Pharm Pract; 2017 Jan; 23(1):26-32. PubMed ID: 26563130
[TBL] [Abstract][Full Text] [Related]
30. Five-year risk of colorectal neoplasia after negative screening colonoscopy.
Imperiale TF; Glowinski EA; Lin-Cooper C; Larkin GN; Rogge JD; Ransohoff DF
N Engl J Med; 2008 Sep; 359(12):1218-24. PubMed ID: 18799558
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of community colorectal cancer screening in 50-74 years old people in Guangzhou, 2015-2016].
Li Y; Liu HZ; Liang YR; Lin GZ; Li K; Dong H; Xu H; Wang M
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):81-85. PubMed ID: 29374902
[No Abstract] [Full Text] [Related]
32. The mean number of adenomas per procedure should become the gold standard to measure the neoplasia yield of colonoscopy: a population-based cohort study.
Denis B; Sauleau EA; Gendre I; Exbrayat C; Piette C; Dancourt V; Foll Y; Ait Hadad H; Bailly L; Perrin P
Dig Liver Dis; 2014 Feb; 46(2):176-81. PubMed ID: 24054769
[TBL] [Abstract][Full Text] [Related]
33. [Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer].
Scintu F; Canalis C; Capra F; D'Alia G; Giordano M; Mocci P; Pisano M; Casula G
Ann Ital Chir; 2000; 71(6):693-9. PubMed ID: 11347322
[TBL] [Abstract][Full Text] [Related]
34. [Participation rate and detection of colorectal neoplasms based on multi-round fecal immunochemical testing for colorectal cancer screening in the Chinese population].
Li N; Zhou YY; Lu M; Zhang YH; Lu B; Luo CY; Luo JH; Cai J; Chen HD; Dai M
Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1041-1050. PubMed ID: 38110312
[No Abstract] [Full Text] [Related]
35. [Lesions detected in a colorectal cancer screening program in the Basque Country: first round (2009-2011)].
Portillo I; Idígoras I; Ojembarrena E; Arana E; Luis Hurtado J; Basurko R; Tapia M; Luz Peña M
Gastroenterol Hepatol; 2013 May; 36(5):301-8. PubMed ID: 23618538
[TBL] [Abstract][Full Text] [Related]
36. Role of community pharmacies in a population-based colorectal cancer screening program.
Vives N; Milà N; Binefa G; Travier N; Farre A; Vidal C; Sattari M; Bagaria G; Garcia M
Prev Med; 2021 Apr; 145():106420. PubMed ID: 33422578
[TBL] [Abstract][Full Text] [Related]
37. Variations between endoscopists in rates of detection of colorectal neoplasia and their impact on a regional screening program based on colonoscopy after fecal occult blood testing.
Bretagne JF; Hamonic S; Piette C; Manfredi S; Leray E; Durand G; Riou F
Gastrointest Endosc; 2010 Feb; 71(2):335-41. PubMed ID: 19922930
[TBL] [Abstract][Full Text] [Related]
38. [Age-specific detection rates of colorectal neoplasms by colonoscopic screening in high-incidence rural area].
Li QL; Ma XY; Yu LL; Xue F; Ma WL; Yao KY
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):154-7. PubMed ID: 23714674
[TBL] [Abstract][Full Text] [Related]
39. [An analysis of results of the elderly colorectal cancer screening study].
Zhang C; Fang Y; Hong Z; Jiang Q; Li W; Li J
Zhonghua Nei Ke Za Zhi; 2014 Sep; 53(9):715-8. PubMed ID: 25511405
[TBL] [Abstract][Full Text] [Related]
40. [Colorectal cancer screening programs in the population at average risk in the European Union and Spain].
Grau J; Serradesanferm A; Polbach S; García-Basteiro AL; Trilla A; Castells A
Gastroenterol Hepatol; 2010 Feb; 33(2):111-8. PubMed ID: 19523716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
